Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

BUY
$7.06 - $23.63 $128,174 - $429,002
18,155 Added 4504.96%
18,558 $155,000
Q1 2022

Apr 12, 2022

BUY
$21.6 - $27.79 $8,704 - $11,199
403 New
403 $9,000
Q4 2021

Jan 18, 2022

SELL
$23.0 - $29.01 $1,150 - $1,450
-50 Closed
0 $0
Q3 2021

Oct 18, 2021

SELL
$25.04 - $30.06 $127,303 - $152,825
-5,084 Reduced 99.03%
50 $1,000
Q2 2021

Jul 16, 2021

SELL
$27.43 - $32.7 $232,496 - $277,165
-8,476 Reduced 62.28%
5,134 $151,000
Q1 2021

Apr 09, 2021

BUY
$21.37 - $34.38 $285,011 - $458,526
13,337 Added 4885.35%
13,610 $432,000
Q4 2020

Jan 11, 2021

SELL
$15.31 - $21.12 $328,996 - $453,847
-21,489 Reduced 98.75%
273 $6,000
Q3 2020

Oct 23, 2020

BUY
$14.88 - $20.13 $323,818 - $438,069
21,762 New
21,762 $338,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.